Axios @axios
Acelyrin, a Los Angeles-based biotech focused on inflammatory diseases like psoriatic arthritis and axial spondyloarthritis, raised $300 million in Series C funding led by Access Biotechnology. https://t.co/kgPR4llNSj — PolitiTweet.org
Created
Thu Sep 15 06:40:24 +0000 2022
Likes
9
Retweets
1
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
Axios @axios
Acelyrin, a Los Angeles-based biotech focused on inflammatory diseases like psoriatic arthritis and axial spondyloarthritis, raised $300 million in Series C funding led by Access Biotechnology. https://t.co/kgPR4llNSj — PolitiTweet.org